Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Dynavax Technologies (DVAX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 454,379
  • Shares Outstanding, K 63,997
  • Annual Sales, $ 8,200 K
  • Annual Income, $ -158,900 K
  • 60-Month Beta 0.70
  • Price/Sales 59.02
  • Price/Cash Flow N/A
  • Price/Book 7.52

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.60
  • Number of Estimates 3
  • High Estimate -0.51
  • Low Estimate -0.69
  • Prior Year -0.63
  • Growth Rate Est. (year over year) +4.76%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.75 +6.22%
on 03/25/19
10.92 -34.34%
on 02/26/19
-3.19 (-30.79%)
since 02/25/19
3-Month
6.75 +6.22%
on 03/25/19
12.42 -42.27%
on 01/16/19
-1.32 (-15.55%)
since 12/24/18
52-Week
6.75 +6.22%
on 03/25/19
22.80 -68.55%
on 04/16/18
-11.33 (-61.24%)
since 03/23/18

Most Recent Stories

More News
Shares of DVAX Down 27.7% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Dynavax Technolo (NASDAQ:DVAX) on February 27th, 2019 at $9.95. In approximately 4 weeks, Dynavax Technolo has returned 27.74% as of today's recent price of $7.19....

DVAX : 7.17 (+0.99%)
Dynavax to Present on Inhaled TLR9 Agonist DV281 at the AACR Annual Meeting 2019

Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on discovering and developing novel vaccines and immuno-oncology therapeutics, today announced it will...

DVAX : 7.17 (+0.99%)
Dynavax Exercises Option for $75 Million in Non-Dilutive Debt

Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that it has exercised its option to draw down $75 million of non-dilutive capital under its existing term loan agreement with CRG Servicing...

DVAX : 7.17 (+0.99%)
Shares of DVAX Down 20.0% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Dynavax Technolo (NASDAQ:DVAX) on February 27th, 2019 at $9.95. In approximately 2 weeks, Dynavax Technolo has returned 20.00% as of today's recent price of $7.96....

DVAX : 7.17 (+0.99%)
Dynavax to Present at 39th Annual Cowen Healthcare Conference

Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on discovering and developing novel vaccines and immuno-oncology therapeutics, today announced that...

DVAX : 7.17 (+0.99%)
Various Industries Search for a Solution to the Spread of Infectious Diseases

The need for sanitization and disinfection is growing, not only in the medical industry but across many other sectors as well. In particular, the medical segment is the biggest driver for the market because...

OGEN : 0.60 (-3.23%)
TTOO : 2.72 (-6.53%)
DVAX : 7.17 (+0.99%)
SCYX : 1.51 (-3.82%)
PCTL : 0.1700 (unch)
Dynavax Announces Fourth Quarter and Full Year 2018 Financial Results

-- Fourth quarter 2018 HEPLISAV-B net product revenue of $3.9 million

DVAX : 7.17 (+0.99%)
Dynavax Technologies to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on February 26

Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on discovering and developing novel vaccines and immuno-oncology therapeutics, will report its fourth...

DVAX : 7.17 (+0.99%)
Recent Analysis Shows Corcept Therapeutics, CDK Global, Dynavax Technologies, ICU Medical, American Vanguard, and Cabot Market Influences -- Renewed Outlook, Key Drivers of Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Corcept Therapeutics Incorporated...

CORT : 11.01 (-1.43%)
CBT : 40.50 (-0.71%)
DVAX : 7.17 (+0.99%)
CDK : 56.35 (+0.21%)
ICUI : 231.55 (+0.99%)
AVD : 17.01 (+0.29%)
Heather Rowe Named Dynavax's Vice President of Investor Relations and Corporate Communications

Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on discovering and developing novel vaccines and immuno-oncology therapeutics, today announced that...

DVAX : 7.17 (+0.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade DVAX with:

Business Summary

Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Dynavax's clinical development...

See More

Key Turning Points

2nd Resistance Point 7.56
1st Resistance Point 7.36
Last Price 7.17
1st Support Level 6.86
2nd Support Level 6.56

See More

52-Week High 22.80
Fibonacci 61.8% 16.67
Fibonacci 50% 14.77
Fibonacci 38.2% 12.88
Last Price 7.17
52-Week Low 6.75

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar